UDG Healthcare (UDHCF) Stock Price, News & Analysis

Company Overview

UDG Healthcare plc (OTCMKTS: UDHCF) is a global provider of outsourced services to the pharmaceutical, biotechnology and medical device sectors. The company offers a comprehensive suite of commercial, clinical and packaging solutions designed to support clients across the entire product lifecycle. UDG Healthcare’s integrated model enables pharmaceutical companies to streamline supply chains, accelerate product launches and enhance patient engagement.

Through its Ashfield division, UDG Healthcare delivers a range of commercial services including field sales forces, medical communications, marketing analytics and patient support programs. Ashfield works closely with global and regional life sciences organizations to develop tailored strategies that drive brand awareness, optimize market access and improve clinical outcomes. The division’s expertise spans managed markets, digital health, training and education for healthcare professionals and direct-to-patient initiatives.

The company’s Sharp division specializes in clinical trial logistics, contract packaging, label management and supply chain solutions. Sharp supports pharmaceutical manufacturers with clinical trial material management, serialization, secondary packaging, bulk manufacturing and cold chain distribution. Its global network of facilities ensures compliance with regulatory requirements and quality standards, enabling efficient delivery of investigational and commercial products to trial sites and end markets.

Founded in Dublin, Ireland, UDG Healthcare has expanded through strategic acquisitions and organic growth since its inception in the 1960s. The company operates in more than 20 countries across Europe, North America and Asia-Pacific, with major hubs in the United Kingdom, the United States, Germany and China. Led by Chief Executive Officer Mike Walsh and a seasoned management team, UDG Healthcare focuses on innovation, operational excellence and long-term partnerships to address evolving challenges in the healthcare industry.

Key Stats

• Today's Range: $14.79 to $14.79
• 50-Day Range: $14.79 to $14.79
• 52-Week Range: $10.86 to $14.79
• Volume: N/A
• Average Volume: 16,957 shs
• Market Capitalization: $3.68 billion
• P/E Ratio: N/A
• Dividend Yield: 1.28%
• Price Target: N/A
• Consensus Rating: N/A

UDHCF Stock Analysis - Frequently Asked Questions

How have UDHCF shares performed this year?

UDG Healthcare's stock was trading at $14.7867 at the beginning of 2025. Since then, UDHCF shares have increased by 0.0% and is now trading at $14.7867.

How do I buy shares of UDG Healthcare?

Shares of UDHCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/14/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Private Households
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:UDHCF
• CIK: N/A
• Web: www.udghealthcare.com
• Phone: (531) 468-9000
• Fax: 353-1459-6893
• Employees: 9,000
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.35
• Current Ratio: 1.90
• Quick Ratio: 1.81

Sales & Book Value

• Annual Sales: $1.28 billion
• Price / Sales: 2.87
• Cash Flow: $0.74 per share
• Price / Cash Flow: 19.91
• Book Value: $3.95 per share
• Price / Book: 3.74

Miscellaneous

• Outstanding Shares: 248,710,000
• Free Float: N/A
• Market Cap: $3.68 billion
• Optionable: Not Optionable
• Beta: 0.62